Customer Centric Marketing USA 2011

Eric Dube has been GlaxoSmithKline Vice President and Business Unit Head of Oncology since December 2008. In that role, he has led the transformation of the business unit to better address customer needs, the emerging portfolio and healthcare industry trends. He previously was Vice President of Managed Markets (November 2007-December 2008), and has held increasingly senior positions within the marketing organization at GSK since December 2001. Eric began his career at GSK as a Senior Regional Medical Scientist in 2000. He earned his Ph.D. in psychology from Cornell University.

Sheila is a Group Leader in the Division of Drug, Marketing, Advertising, and Communications (DDMAC) at the FDA. She joined the FDA in 2003 as a regulatory project manager in the Division of Drug Oncology Product after having held various pharmacy positions in the private sector. She came to DDMAC in 2005 as a professional regulatory reviewer and has been a professional group leader since November 2007. She currently oversees the promotion of anti-infective, anti-viral, dental, ophthalmology, dermatology, cardiology, and nephrology drug products. Sheila holds pharmacy degrees from the University of Pittsburgh and the University of Maryland. She is currently pursuing a Master of Public Health degree from the University of North Carolina. She is also a Commander in the US Public Health Service.

Harold Johns is an IT Manager with 17 years experience at Johnson and Johnson. For the past 5 years, his group has been responsible for developing Digital Marketing programs for the Pharmaceutical sector of J&J across North America, Europe, and Asia Pacific. They support over 30 brands and 300 web properties including product sites, unbranded sites, HCP resource centers, and virtual selling portals. They also build and manage e-mail marketing campaigns, e-detailing and virtual rep capabilities, mobile and social networking applications. He currently resides in Doylestown PA with his wife, 3 kids and 2 dogs and is the Treasurer of the Bucks County Foster Parent Association, a volunteer coach with the CB West Girls HS volleyball team, and on the Doylestown Open Space Preservation Committee.

Pam Alexa, began her career as a RN and specializing in burns. These skills were well needed when she served as an Officer and nurse in the US Army during Operation Desert Storm, in an EVAC Hospital stationed in Saudi Arabia. Pam joined Johnson and Johnson as a pharmaceutical hospital sales representative. She advanced her career and has held various leadership positions in pharmaceutical and consumer marketing, where she launched new products and new indications. Pam joined Wyeth in 2006 as the U.S. Commercial Lead commercial lead for Vaccines. In 2007, she became the lead for Vaccine Global Strategic Marketing. When Pfizer acquired Wyeth in 2009, she became as the US Commercial Lead for Vaccines. Pam and her team are responsible for the market success for both the pediatric and adult vaccines. In 2010, they launched Prevnar Prevnar 13 Pediatric, the most successfully launched product in US pharmaceutical history. Pam received her MBA from Northwestern University, Kellogg School of Management. She and her husband, Bruce Moreno, live in Doylestown, Pennsylvania.

Lisa Riedell has a broad experience in the pharmaceutical industry with over 13 years of professional sales and marketing at sanofi-aventis. Lisa has worked in CNS marketing for the past 3 years, in the areas of Multiple Sclerosis, ALS and Sleep Disorders. Her marketing expertise includes Medical Education, Complementary Channel Marketing, Managed Markets, and Consumer marketing. Lisa currently resides in Fanwood, NJ with her husband and 2 children.

Ashok brings over 26 years of experience from North America and International markets. He was Commercial Director for Pacific, Asia, Australia and Africa with Abbott International prior to his 10 years with Abbott in North American Market in marketing, sales, business development, health communication and pharmacy programs. He also worked recently with IMS Health Americas as Director, National Accounts managing retail and wholesale accounts, prior to IMS and Abbott, he also worked in International markets as General Manager, Sales Manager and Group Product Manager with Johnson and Johnson and Parke Davis. He has successfully launched several new products in primary care, specialty, devises and OTC area. Ashok has completed his Masters degree in Pharmaceutical Sciences and MBA. Ashok is also President of Thyroid Foundation of Canada and serves on the board of Thyroid Federation International.

David S. Williams III is Chief Marketing Officer and Head of Business Development at PatientsLikeMe, where he is responsible for the corporate brand, patient acquisition, business strategy, and client services. Author of the company’s groundbreaking Openness Philosophy, Williams has developed a number of products and services for industry partners that amplify the patient voice and experience with chronic health conditions. He also developed a product that accelerates clinical trial recruitment and helps pharmaceutical partners bring breakthrough treatments to market faster. A recognized thought leader in pharma interaction with social media, he has been quoted in Marketwatch, Bio-IT World, PharmaTimes and numerous trade publications. He is also published author in Nature Biotechnology and the Journal of Communication in Healthcare. Prior to joining PatientsLikeMe, Williams held institutional sales and global strategy positions at pharmaceutical leader Eli Lilly and Company, with a focus on the psychiatry and neurology therapeutic areas. He also built online health communities numbering in the hundreds of thousands as Director of Community Development at venture-backed health media firm, Spotlight Health. Earlier in his career, Williams was a management consultant with Deloitte’s health care practice, focusing on hospital strategy, mergers and acquisitions, and health plan evidence-based utilization management. A successful entrepreneur, Williams founded two companies before age 30, guest lectures at several major business schools, and serves on the Board of Advisors for the Price Center for Entrepreneurial Studies at UCLA. He earned his B.S. from The Wharton School at University of Pennsylvania and holds an MBA from the UCLA Anderson Graduate School of Management.

Daniel Palestrant is Founder and Chief Executive Officer of Cambridge-based Sermo, Inc. As CEO, Daniel is responsible for the overall vision of the Sermo community and business. His main tasks focus on ensuring that Sermo is a valuable resource to physicians while building a profitable and socially responsible enterprise. Daniel's first experiences with Healthcare Informatics came when he conceived, designed, proposed and managed deployment of CIBUR (CIGNA Internet Based Universal Resource), one of the first commercial Web-based healthcare resources for physicians and allied health professionals. No stranger to the entrepreneurial side of medicine, Daniel founded his first company, Azygos, Inc. After selling Azygos, Daniel joined BioNetrix (Now BNX Systems) as Director of Health Care. Daniel has done clinical and laboratory research in transplant immunology. He has a B.S. in biology from Johns Hopkins University, completed medical school at Duke University, and trained in General Surgery at Beth Israel-Deaconess Hospital, in Boston before leaving to launch Sermo.

Earl Whipple is a global public affairs, communications and PR professional who has led strategic communications and stakeholder outreach for two Fortune 100 companies, three Members of Congress and a cabinet agency of the US government. He has been a management consultant for IBM Global Services and a Chief of Staff and Legislative Director in the United States House of Representatives. Earl has expertise in strategic counsel and executive messaging, crisis and issues management communications, reputation influencing, and social media strategy and stakeholder outreach. For the last five and a half years he was the Senior Director of Corporate Communications for AstraZeneca. In 2011, Earl launched Consilium Engagement Strategies specializing in public affairs, communications, digital stakeholder engagement, and crisis and issues management. These areas individually and holistically are core to reputational influencing. Earl is on the board of the International Association of Business Communicators - Philadelphia Region, Pharma 20/20, and is a member of the Public Affairs Committee of the Union League of Philadelphia. Earl is also a member of the Innovatorʼs Circle Committee with the Abington Memorial Hospital Foundation. Earl holds an MBA from The Fuqua School of Business at Duke University and a BA from Dickinson College.

Ray is the Commissioner and Chief Executive Officer of the autonomous Pharmaceutical Advertising Advisory Board and is responsible for operations and the administration of the preclearance review mechanism. He has held management positions in community, hospital and government pharmacy and served on the Ontario College of Pharmacists Council, chairing five committees. Ray achieved a Pharmacy degree from the University of Toronto, a Master in International Business (Marketing) degree from the University of South Carolina and a Medical Marketing Certicate from UCLA. He is a Certified Association Executive by the Canadian Society of Association Executives. He has received a United Nations medal for peacekeeping which led to the Nobel Peace Prize in 1996 for all U.N. peacekeepers. He was inducted into the Canadian Healthcare Marketing Hall of Fame in 2009.

Barbara is an award-winning journalist, media broadcaster, medical blogger, speaker, health expert, consultant and registered nurse. She is founder and editor-in-chief of Healthin30.com. Barbara is a featured writer at The Huffington Post, and she is on the Editorial Advisory Board and consumer health educator for ShareCare. She is an expert nurse curator and top health communicator at OrganizedWisdom. Barbara is head nurse (nursing supervisor) at a level 2 trauma center and covers multiple medical and surgical units; including critical care, oncology, cardiology, psychiatric in-patient unit and the women’s and children’s units including the pediatric emergency room. Her clinical experience ranges from oncology to general medicine and surgery. She is a guest blogger for many health sites. Her professional affiliations include the Association of Health Care Journalists, New York Women in Communications, Microsoft Health Users Group (MSHUG), HIMSS (Healthcare Information and Management Systems Society), and she is president of Barbara Ficarra Productions, LLC. Barbara is a leading nurse voice in health and her focus is on Patient Empowerment, Patient Engagement, Health Care Social Media and Healthy Living.

Dr. Joseph Kim is a physician technologist who has a passion to leverage health information technology to improve public health. He currently works in the medical education industry and he also actively writes about mobile health, health information technology, and non-clinical career opportunities for physicians. Dr. Kim received a B.S. in engineering from the Massachusetts Institute of Technology, an M.D. from the University of Arkansas College of Medicine, and an M.P.H. from the University of Massachusetts Amherst School of Public Health. He is currently enrolled in the Executive Pharmaceutical & Healthcare Marketing MBA at Saint Joseph's University's Erivan K. Haub School of Business.

A veteran of the pharmaceutical industry, Janet honed her marketing skills at Parke-Davis, then joined NCI Advertising where she created unique marketing programs for pharmaceutical clients. Upon joining the Medical News Network, the entrepreneurial chapter of her life began. In 1994, Janet launched One Eleven Interactive, focusing on the Internet and marketing to healthcare professionals. Today, One Eleven Corporation has two divisions: One Eleven Software, the market leader for Internet and mobile sampling to top pharma companies via SampleServer®, and Bridge 6, a ground-breaking physician-facing social and mobile media digital agency.

Coming Soon...

Coming Soon...

Joanna is Vice President and Social Media Manager for Global Public Affairs at Citi. Her team is responsible for Citi’s corporate social media channels, including @Citi, Citi’s YouTube Channel and the Citi Global Facebook page. She works closely with legal, compliance and information security to develop social media guidelines and procedures for Citi businesses globally. Before landing in her current role, she spent two years as a Video Producer and Editor for Citi’s Institutional Clients Group. Prior to joining Citi, Joanna was an Environmental Scientist based in Dallas, TX, where in addition to specializing in natural resource management, she successfully integrated digital media materials into regulatory compliance requirements for transportation agencies and private clients. Joanna graduated from New York University where she studied Earth Science and Film & Television.

Coming Soon...

Aaron has been in the pharmaceutical industry for the past six years and served as an officer in the military prior to this. His career with sanofi aventis began in field sales, where he worked in various capacities, before entering his current role in Closed Loop Marketing. He is also currently pursuing his MBA through the University of North Carolina-Chapel Hill.

Wendy has more than 17 years' experience in pharmaceutical and health care marketing, including digital, public relations b-to-b. Her blog, ePharma Rx, has become a must-read authoritative voice in the ePharma arena. Wendy is responsible for brand strategy, client service, and business development across the agency, interfacing with a number of Intouch’stop-20 pharma clientele. During her 8 years at Intouch Solutions, Wendy has helped grow the firm into a premier digital health care agency, recognized as Med Ad News’ 2010 "Agency of the Year.” Prior to joining Intouch, Wendy was a Vice President at global PR agency Fleishman-Hillard. She spent five years there developing award-winning programs for Bayer Healthcare, Pfizer Animal Health and Ocean Spray. Wendy also served the biotech industry during time at Godbe Communications, an integrated marketing communications firm in the biotech and tech-centric Silicon Valley of California. Wendy graduated magna cum laudefrom Drury University with a degree in Communications.

Coming Soon...

Over the years, Alfred has worn many hats. During his 20+ years in the marketing world, Alfred has been a copywriter, a creative director, a CRM strategist (for AstraZeneca and Pfizer), and president of a pharmaceutical interactive agency.

Alfred came to the health care industry mid-career and his passion for patient-centric marketing – seeing it holistically and seeing it from the patient’s perspective – occurred after a personal experience galvanized him to move from mass market work to health care. When his sister got a Stage 4 melanoma diagnosis, his family designated him as the “family researcher” on the condition and options; having seen how little existed offline and online , his sister’s passing made him realize that all his earlier consumer and B to B experience could influence how to speak and market to patients…and provide them the much-needed information and support they need. Alfred has a firm belief that eventually, Biopharma companies will move from sales/manufacturing driven, to service organizations meant to acquire, retain and support patients and doctors.

Alfred revels in thinking strategically...he’s spent his early years working creatively...and has become a champion for the patient wholeheartedly.

Karl is an award-winning writer and marketing strategist with nearly two decades experience helping healthcare companies tell their stories to attract customers and investors. He boasts the unique ability to bridge the life sciences with the digital worlds. An advisor to numerous startups, Karl is the founder of MessagingLab, a branding firm that focuses on healthcare companies developing disruptive technologies. Previously, he worked at GCI Healthcare, Xceed, and Noonan/Russo. Trained as a molecular biologist, Karl holds an M.S. in biochemistry and an M.F.A. in creative writing and is currently writing a book on the impact of social media on the practice of medicine. He is fluent in Spanish, French and German.

Coming soon...

Mary Clark joined Intouch Solutions in March 2010 with more than 12 years of user-centered experience, including customer support, content writing, project management, qualitative user research and interaction design. She is an experienced research moderator and has coordinated user experience and usability testing for health care, telecommunications, financial services, consumer packaged goods, retail, transportation and restaurants. As a champion of user-centered design at Intouch Solutions, Clark will provide research, evaluation and experience design services for current clients and new business. She has a bachelor’s degree from the University of Kansas.

Deborah Schnell has almost 35 years experience in Business to Business selling, leading high-performing teams selling strategic business solutions. Ms. Schnell earned a BS degree from Miami of Ohio in 1976 and worked for IBM for almost 20 years. During her tenure with IBM, she held positions of increasing responsibility in sales, sales training, marketing and brand management. In 1996, Deborah helped launch ProtoCall, a pharmaceutical contract sales organization that allowed for "shared" sales resources with an innovative targeted access approach to sales force deployment. As President, she was instrumental in positioning the company for sale to PDI – a publicly traded contract sales organization, in 1999. In 2002, she was named a corporate officer of PDI and Executive Vice President of Business Development where she led the company’s rapid growth and helped establish their market dominance, capturing 55% of the industry market share. Deborah joined Healthy Advice Networks in May of 2005, helping build the company into the largest point-of-care provider in the United States, currently accounting for over 25% of the scrip volume.